je.st
news
Cubist sees promising test results in treating children with C. difficile
2014-10-09 13:42:44| Biotech - Topix.net
Cubist is testing a new antibacterial in children which has the potential to fight a serious type of diarrhea common to cancer patients called Clostridium difficile more effectively and cheaply than current drugs. The Lexington drug company plans to present results of an early-stage trial this weekend which it says will give early insight into the possibility of using a drug it acquired last year, called Dificid, in kids.
Tags: results
test
children
sees
Category:Biotechnology and Pharmaceuticals